Three Months Ended

Six Months Ended

Numerator:

Net income (loss)

$

(1,280,376

)

(2,929,708

)

5,779,663

$

(9,245,295

)

Accrued dividends on Series F Preferred Stock

(52,038

)

(49,748

)

(119,688

)

(110,983

)

Deemed dividends

(3,677,811

)

(7,751

)

(4,734,143

)

(5,257,455

)

Numerator for basic EPS - net income (loss) available to common stockholders

(5,010,225

)

(2,987,207

)

925,832

(14,613,733

)

Effect of convertible securities and liability classified equity instrument:

Accrued dividends on Series F Preferred Stock

—

119,688

—

Interest expense on convertible note payable

—

45,150

—

Gain on change in fair value of warrant liabilities

—

(8,506,000

)

—

Numerator for diluted EPS - net loss available to common stockholders

$

(5,010,225

)

$

(2,987,207

)

$

(7,415,330

)

$

(14,613,733

)

Denominator:

Denominator for basic EPS - weighted average shares

15,524,049

247,728

13,835,214

205,788

Effect of dilutive securities:

Incremental shares for outstanding warrants

—

4,837,593

—

Convertible Series F Preferred Stock

—

2,485,654

—

Unvested restricted stock units

—

68,797

—

Denominator for diluted EPS - weighted average shares

15,524,049

247,728

21,227,258

205,788

Net income (loss) per common share - basic

$

(0.32

)

$

(12.06

)

$

0.07

$

(71.01

)

Net loss per common share - diluted

$

(0.32

)

$

(12.06

)

$

(0.35

)

$

(71.01

)